Syndax Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $229,954,000.
Profit Margin
| 2014 | 0 | -19.82M | |
|---|---|---|---|
| 2015 | 627K | -24.11M | -3846.73% |
| 2016 | 1.22M | -44.47M | -3645.25% |
| 2017 | 2.10M | -60.80M | -2884.35% |
| 2018 | 1.51M | -73.96M | -4875.48% |
| 2019 | 1.51M | -55.95M | -3688.53% |
| 2020 | 1.51M | -73.06M | -4816.68% |
| 2021 | 139.70M | 24.92M | 17.84% |
| 2022 | 0 | -143.74M | |
| 2023 | 0 | -209.36M |
SNDX Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 139.70M | 1.51M | 1.51M | 1.51M | 2.10M | 1.22M | 627K | 0 |
Cost of revenue | 12K | 454K | 456K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | -12K | -454K | 139.25M | 1.51M | 1.51M | 1.51M | 2.10M | 1.22M | 627K | 0 |
Operating exp. | ||||||||||
Research and development | 163.03M | 118.49M | 88.24M | 50.43M | 42.99M | 60.10M | 48.20M | 31.66M | 9.54M | 10.17M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 229.95M | 151.75M | 113.48M | 72.94M | 59.05M | 77.39M | 64.06M | 44.98M | 21.14M | 21.33M |
Operating income | -229.95M | -151.75M | 26.22M | -71.42M | -57.53M | -75.87M | -61.95M | -43.76M | -20.51M | -21.33M |
Other income (expenses), net | 20.59M | 2.41M | -1.29M | -1.73M | 1.49M | 1.91M | 1.15M | -706K | -3.60M | 1.50M |
Income before tax | -209.36M | -149.33M | 24.92M | -73.15M | -56.04M | -73.96M | -60.80M | -44.47M | -24.11M | -19.82M |
Income tax expense | 0 | -5.58M | -43K | -89K | -92K | 1.91M | -76K | -89K | 1.53M | -1.5M |
Net income | -209.36M | -143.74M | 24.92M | -73.06M | -55.95M | -73.96M | -60.80M | -44.47M | -24.11M | -19.82M |
Earnings per share | ||||||||||
Basic EPS | -2.98 | -2.37 | 0.48 | -1.77 | -1.84 | -2.92 | -2.9 | -3.04 | -1.39 | -2.07 |
Diluted EPS | -2.98 | -2.37 | 0.46 | -1.77 | -1.84 | -2.92 | -2.9 | -3.04 | -1.39 | -2.07 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |